| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Bleak prospects for HIV response under new US administration
|
The Lancet HIV,
|
|
|
12 |
1 |
p. e1
|
article
|
| 2 |
Closing the gap to UNAIDS 95-95-95: Lesotho's success story
|
Hatzold, Karin
|
|
|
12 |
1 |
p. e6-e8
|
article
|
| 3 |
Coffee with IAS President Beatriz Grinsztejn
|
Kirby, Tony
|
|
|
12 |
1 |
p. e10-e11
|
article
|
| 4 |
Effectiveness of bi-monthly long-acting injectable cabotegravir and rilpivirine as maintenance treatment for HIV-1 in the Netherlands: results from the Dutch ATHENA national observational cohort
|
Jongen, Vita W
|
|
|
12 |
1 |
p. e40-e50
|
article
|
| 5 |
Effect of a multicomponent, person-centred care intervention on client experience and HIV treatment outcomes in Zambia: a stepped-wedge, cluster-randomised trial
|
Sikombe, Kombatende
|
|
|
12 |
1 |
p. e26-e39
|
article
|
| 6 |
Fostering healthy cognitive ageing in people living with HIV
|
Cysique, Lucette A
|
|
|
12 |
1 |
p. e71-e80
|
article
|
| 7 |
Improving quality of interpersonal care in HIV programmes
|
Tlhaku, Kwena
|
|
|
12 |
1 |
p. e3-e5
|
article
|
| 8 |
Injectable antiretrovirals: real world or ideal world?
|
Harris, Marianne
|
|
|
12 |
1 |
p. e5-e6
|
article
|
| 9 |
Lesotho's progress towards UNAIDS 95-95-95 targets from 2016 to 2020: comparison of Population-based HIV Impact Assessments
|
Farahani, Mansoor
|
|
|
12 |
1 |
p. e51-e59
|
article
|
| 10 |
Potential for broadly neutralising antibodies as PrEP
|
Fidler, Sarah
|
|
|
12 |
1 |
p. e2-e3
|
article
|
| 11 |
Recent gay Black history in the UK
|
Burki, Talha
|
|
|
12 |
1 |
p. e12
|
article
|
| 12 |
Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial
|
Edupuganti, Srilatha
|
|
|
12 |
1 |
p. e13-e25
|
article
|
| 13 |
Screening for chlamydia and incidence of symptomatic infections
|
Vanbaelen, Thibaut
|
|
|
12 |
1 |
p. e9
|
article
|
| 14 |
Sex as a biological variable in HIV-1 and schistosome co-infection
|
Maganga, Jane K
|
|
|
12 |
1 |
p. e60-e70
|
article
|
Journal description